B. Gaudillière

Chapter 26. To market, to market - 2001

P. Bernardelli, B. Gaudillière, F. Vergne, 2002 .

Chapter 31. To Market, To Market - 1998

B. Gaudillière, 1999 .

Preparation of azaindolines and benzoyl substituted azaindolines: precursors of triazabenzo[cd]azulen-9-one PDE4 inhibitors

C. Durand, V. Fasquelle, H. Jacobelli, 2011 .

New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.

C. Durand, V. Fasquelle, H. Jacobelli, 2004, Bioorganic & medicinal chemistry letters.

Chapter 28. To market, to market — 2000

P. Berna, P. Bernardelli, B. Gaudillière, 2001 .

Section VII. Trends and perspectives

P. Berna, Bernard Gaudillière, Patrick Berna, 2000 .

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

D. Duverger, E. Mackenzie, C. Carter, 1988, The Journal of pharmacology and experimental therapeutics.